| |
| |
|
| Insider
Information: |
Kim Helen Susan |
| Relationship: |
Director |
| City: |
Hayward |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
591,681 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$155,224 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
591,681 |
|
|
| Total
Value |
$155,224 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -83.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
ImmunoCellular Therapeutics Ltd |
IMUC |
Director |
2012-05-25 |
1,667 |
|
0 |
Premium* |
|
|
Kite Pharma, Inc. |
KITE |
EVP, Business Developm... |
2017-10-03 |
0 |
2015-12-17 |
0 |
Premium* |
|
|
Applied Molecular Transport Inc. |
AMTI |
Director |
2021-08-25 |
590,014 |
2020-07-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMTI |
Applied Molecular Transpo... |
Director |
– • – |
2021-08-25 |
4 |
AS |
$30.08 |
$285,075 |
D/D |
(9,478) |
590,014 |
0 |
% |
|
| AMTI |
Applied Molecular Transpo... |
Director |
– • – |
2021-08-24 |
4 |
AS |
$30.03 |
$15,255 |
D/D |
(508) |
599,492 |
0 |
% |
|
| AMTI |
Applied Molecular Transpo... |
Director |
– • – |
2021-07-02 |
4 |
S |
$43.30 |
$8,663,731 |
D/D |
(200,000) |
600,000 |
0 |
% |
|
| AMTI |
Applied Molecular Transpo... |
Director |
– • – |
2020-07-02 |
4 |
OE |
$0.02 |
$16,000 |
D/D |
800,000 |
800,000 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Business Development |
• – – |
2017-10-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(17,500) |
0 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Business Development |
• – – |
2017-10-03 |
4 |
D |
$180.00 |
$754,740 |
D/D |
(4,193) |
17,500 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Business Development |
• – – |
2017-09-25 |
4 |
S |
$179.66 |
$569,714 |
D/D |
(3,171) |
21,693 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Business Development |
• – – |
2017-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
24,864 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Business Development |
• – – |
2017-08-10 |
4 |
OE |
$51.43 |
$330,369 |
D/D |
6,251 |
24,915 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Business Development |
• – – |
2017-08-10 |
4 |
AS |
$120.09 |
$750,683 |
D/D |
(6,251) |
18,664 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Business Development |
• – – |
2017-08-08 |
4 |
AS |
$115.02 |
$9,558,324 |
D/D |
(79,949) |
18,664 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Business Development |
• – – |
2017-08-08 |
4 |
OE |
$53.90 |
$4,309,251 |
D/D |
79,949 |
98,613 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Business Development |
• – – |
2017-07-31 |
4 |
AS |
$108.75 |
$2,912,272 |
D/D |
(26,649) |
18,664 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Business Development |
• – – |
2017-07-31 |
4 |
OE |
$51.43 |
$1,411,437 |
D/D |
26,649 |
45,313 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Business Development |
• – – |
2017-06-01 |
4 |
AS |
$72.45 |
$173,880 |
D/D |
(2,400) |
18,664 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Business Development |
• – – |
2017-06-01 |
4 |
OE |
$51.43 |
$123,432 |
D/D |
2,400 |
21,064 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Business Development |
• – – |
2017-05-01 |
4 |
AS |
$82.12 |
$197,088 |
D/D |
(2,400) |
18,664 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Business Development |
• – – |
2017-05-01 |
4 |
OE |
$53.90 |
$129,360 |
D/D |
2,400 |
21,064 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Business Development |
• – – |
2017-04-03 |
4 |
S |
$81.80 |
$196,320 |
D/D |
(2,400) |
18,664 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Business Development |
• – – |
2017-04-03 |
4 |
OE |
$53.90 |
$129,360 |
D/D |
2,400 |
21,064 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Business Development |
• – – |
2017-03-01 |
4 |
AS |
$68.95 |
$181,039 |
D/D |
(2,400) |
18,664 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Business Development |
• – – |
2017-03-01 |
4 |
OE |
$53.90 |
$129,360 |
D/D |
2,400 |
21,064 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Business Development |
• – – |
2017-02-28 |
4 |
AS |
$63.00 |
$3,228,372 |
D/D |
(47,900) |
18,664 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Business Development |
• – – |
2017-02-28 |
4 |
OE |
$51.43 |
$2,503,756 |
D/D |
47,900 |
66,564 |
0 |
- |
|
| KITE |
Kite Pharma, Inc. |
EVP, Business Development |
• – – |
2016-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
10,600 |
18,664 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
